Clinical Trial Update: A Study to Evaluate the Safety and Tolerability of Eravacycline in Pediatric Patients Aged 8 to 17 With Complicated Intra-abdominal Infections (cIAI) [Phase 2]

View source ↗

Summary

A Phase 2 pediatric trial is evaluating the safety and tolerability of eravacycline in children aged 8 to 17 with complicated intra-abdominal infections; the st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Complicated Intra-abdominal Infections

Drugs mentioned

• XERAVA (eravacycline)

Snippet

Sponsor: Tetraphase Pharmaceuticals, Inc | Conditions: Complicated Intra-abdominal Infections (cIAI) | Phase 2 | Status: RECRUITING